Research & Development



  “我當時尿褲子了。”   劉陵可不會為匈奴的千秋萬代著想,她只想成為匈奴至高無上的女王,只要手下有人可以供她驅馳,她才不在乎這些人到底是誰。中文字幕大香蕉永久网   蒙查恨恨的搖頭道︰“不會!”中文字幕手机在线香蕉   最了解孟大,孟二的人不是他們的父母,也不是雲瑯,曹襄這些旁觀者,而是已經融入到孟大,孟二生活里的小蟲。   雲瑯也疲憊的靠在另外一箱白玉上,隨手抓起兩顆珍珠一丟一丟的道︰“讓我好好想想你的壞處,下次再罵。”香蕉伊人影院在线观看不卡   也不知什麼原因,或許是雲瑯自己也是一身臭汗的緣故,所以他也很快就下水了。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo